The pandemic is a chance to revamp India’s pharmaceutical industry

by Philippa Kaur 9 May 2020, 00:00 199 Views

Companies could switch from primarily making generics to producing higher-margin licensed drugs

Wall Street weekahead: U.S. data deluge to underscore divide between roaring market, plunging economy

Global Fintech Firm Launches Security Tokenization Platform

This portal is not a newspaper as it is updated without periodicity. It cannot be considered an editorial product pursuant to law n. 62 of 7.03.2001. The author of the portal is not responsible for the content of comments to posts, the content of the linked sites. Some texts or images included in this portal are taken from the internet and, therefore, considered to be in the public domain; if their publication is violated, the copyright will be promptly communicated via e-mail. They will be immediately removed.

The pandemic is a chance to revamp India’s pharmaceutical industry

Wall Street weekahead: U.S. data deluge to underscore divide between roaring market, plunging economy

Global Fintech Firm Launches Security Tokenization Platform

ITALIAN LANGUAGE

ENGLISH LANGUAGE